BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 19196070)

  • 1. Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells.
    Toka FN; Nfon CK; Dawson H; Estes DM; Golde WT
    J Interferon Cytokine Res; 2009 Mar; 29(3):179-92. PubMed ID: 19196070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with foot-and-mouth disease virus (FMDV) induces a natural killer (NK) cell response in cattle that is lacking following vaccination.
    Patch JR; Dar PA; Waters R; Toka FN; Barrera J; Schutta C; Kondabattula G; Golde WT
    Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):249-57. PubMed ID: 25150134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR; Renauld JC; Houssiau FA
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
    Pintaric M; Gerner W; Saalmüller A
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and transient activation of γδ T cells to IFN-γ production, NK cell-like killing, and antigen processing during acute virus infection.
    Toka FN; Kenney MA; Golde WT
    J Immunol; 2011 Apr; 186(8):4853-61. PubMed ID: 21383249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O; Mami-Chouaib F; Moreau JL; Thèze J; Chehimi J; Chouaib S
    Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
    Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
    Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of cytokine-induced proliferation of human Natural Killer cells by intravenous immunoglobulin G.
    Issekutz AC; Derfalvi B; Käsermann F; Rowter D
    Clin Immunol; 2015 Dec; 161(2):373-83. PubMed ID: 26307433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
    Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G
    J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
    Sun R; Li AL; Wei HM; Tian ZG
    Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2.
    Lee SH; Yun S; Piao ZH; Jeong M; Kim DO; Jung H; Lee J; Kim MJ; Kim MS; Chung JW; Kim TD; Yoon SR; Greenberg PD; Choi I
    J Immunol; 2010 Jul; 185(2):917-28. PubMed ID: 20543098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of proinflammatory cytokines without invocation of cytotoxic effects by an Epstein-Barr virus-infected natural killer cell line established from a patient with hypersensitivity to mosquito bites.
    Suzuki D; Tsuji K; Yamamoto T; Fujii K; Iwatsuki K
    Exp Hematol; 2010 Oct; 38(10):933-44. PubMed ID: 20600581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
    Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
    J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of IL-17 upon human natural killer cells.
    Al Omar S; Flanagan BF; Almehmadi M; Christmas SE
    Cytokine; 2013 Apr; 62(1):123-30. PubMed ID: 23490420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4.
    Knoblock KF; Canning PC
    Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists.
    Toka FN; Nfon CK; Dawson H; Golde WT
    Clin Vaccine Immunol; 2009 Jun; 16(6):866-78. PubMed ID: 19369481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-21 induces proliferation and modulates receptor expression and effector function in canine natural killer cells.
    Shin DJ; Lee SH; Park JY; Kim JS; Lee JJ; Suh GH; Lee YK; Cho D; Kim SK
    Vet Immunol Immunopathol; 2015 May; 165(1-2):22-33. PubMed ID: 25819349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.
    Matikainen S; Paananen A; Miettinen M; Kurimoto M; Timonen T; Julkunen I; Sareneva T
    Eur J Immunol; 2001 Jul; 31(7):2236-45. PubMed ID: 11449378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.